Clinical Pharmacology & Therap is categorized under Periodical Publishers in Philadelphia, PA .
Clinical Pharmacology & Therap was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Periodical Publishers business, which does work in the B2B market, and is classified as a Periodical Publishers, under code number 5111200 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 1600 John F Kennedy Boulevard # 1800, Philadelphia, Pennsylvania PA 19103 or by phoning (215) 239-3714. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinical Pharmacology & Therap |
| Address: | 1600 John F Kennedy Boulevard # 1800, Philadelphia, Pennsylvania 19103 |
| Phone Number: | (215) 239-3714 |
| Website Address: | elsevier.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Periodical Publishers |
| SIC Code: | 2721 |
| NAICS Code: | 5111200 |
| Share This Business: |
Clinical Pharmacology & Therap was started in 0 to provide professional Periodical Publishers under the SIC code 2721 and NAICS code 5111200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact for inquiries that concern Clinical Pharmacology & Therap by calling the company number (215) 239-3714, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Pharmacology & Therap can be found at the coordinates 39.953751,-75.166673 as well as the street address 1600 John F Kennedy Boulevard # 1800 in Philadelphia, Pennsylvania 19103.
For its online presence, you may visit Clinical Pharmacology & Therap’s website at elsevier.com and engage with its social media outlets through on Twitter and on Facebook.